Bio-Techne CorporationTECHNASDAQ
LOADING
|||
R&D Expense Growth Under Pressure
Trending lower, below historical average.
Left:
||||
Year-over-year research & development expense growth
Latest
-6.88%
↓ 434% below average
Average (39q)
2.06%
Historical baseline
Range
High:21.52%
Low:-6.88%
CAGR
+2.1%
Modest growth trend
| Period | Value |
|---|---|
| Q3 2025 | -6.88% |
| Q2 2025 | 5.91% |
| Q1 2025 | -1.75% |
| Q4 2024 | 4.81% |
| Q3 2024 | -0.50% |
| Q2 2024 | -6.88% |
| Q1 2024 | 12.41% |
| Q4 2023 | -4.51% |
| Q3 2023 | 2.47% |
| Q2 2023 | 3.11% |
| Q1 2023 | 1.13% |
| Q4 2022 | -6.04% |
| Q3 2022 | 3.26% |
| Q2 2022 | 6.47% |
| Q1 2022 | 5.29% |
| Q4 2021 | -4.40% |
| Q3 2021 | 4.24% |
| Q2 2021 | 21.52% |
| Q1 2021 | 1.57% |
| Q4 2020 | 4.66% |
| Q3 2020 | -4.40% |
| Q2 2020 | 5.17% |
| Q1 2020 | -2.61% |
| Q4 2019 | 1.89% |
| Q3 2019 | -1.12% |
| Q2 2019 | 4.55% |
| Q1 2019 | -1.64% |
| Q4 2018 | 6.92% |
| Q3 2018 | 5.79% |
| Q2 2018 | 0.63% |
| Q1 2018 | -0.14% |
| Q4 2017 | 2.68% |
| Q3 2017 | -1.09% |
| Q2 2017 | -0.54% |
| Q1 2017 | 3.69% |
| Q4 2016 | 4.04% |
| Q3 2016 | 9.64% |
| Q2 2016 | 3.54% |
| Q1 2016 | 2.44% |
| Q4 2015 | -3.05% |